Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RhPSMA-7.3(18F)-PET Scan to Detect Prostate Cancer in Patients with Early PSA Recurrence

NCT06617481 is registered in ClinicalTrials.gov with AdventHealth as lead sponsor.

NCT NCT06617481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06617481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RhPSMA-7.3(18F)-PET Scan to Detect Prostate Cancer in Patients with Early PSA Recurrence
Lead sponsor
AdventHealth
Phase
Phase 2
Overall status
Recruiting
Start date
September 20, 2024
Completion date
October 10, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (post prostatectomy)